An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine
โ Scribed by T. Edeki; A. Johnston; P. Turner
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 350 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
โฆ Synopsis
The influence of 2 weeks oral intake of nifedipine (2 x 20 mg) on the oxidative metabolism of antipyrine was investigated in 12 normal volunteers, who had 1050 mg antipyrine solution orally before and after the course of nifedipine. There were no statistically significant differences in the saliva pharmacokinetic parameters of antipyrine on both occassions. However, the metabolite profile of antipyrine in urine showed a significant reduction in the amount of norantipyrine excreted after compared to that before nifedipine administration (16.5 vs 19.6%). This may have implications for drugs that share a similar demethylation pathway with norantipyrine.
๐ SIMILAR VOLUMES
The possibility of a pharmacokinetic interaction between isosorbide-5-mononitrate (5-ISMN) and epinine, the active metabolite of ibopamine, has been investigated in 8 healthy male subjects given single doses of 200 mg ibopamine and 20 mg 5-ISMN, separately and together. The plasma 5-ISMN concentrati
The effects of piroxicam (40 mg) on the pharmacokinetics of ranitidine (150 mg) and of ranitidine (150 mg bid) on the pharmacokinetics of piroxicam (20 mg) were assessed in two 2-way crossover studies in two groups of 18 healthy male subjects. In the first study there were no statistically significa